HHGA
GNOM icon

Halbert Hargrove Global Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Halbert Hargrove Global Advisors’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.1K Hold
1,093
– – ﹤0.01% 200
2026
Q1 		$47.8K Hold
1,093
– – ﹤0.01% 195
2025
Q4 		$49.7K Sell
1,093
-2,326
-68% -$103K ﹤0.01% 189
2025
Q3 		$133K Sell
3,419
-2
-0.1% -$72 0.01% 124
2025
Q2 		$115K Buy
3,421
+2,209
+182% +$69.9K 0.01% 108
2025
Q1 		$38.5K Sell
1,212
-886
-42% -$33.6K ﹤0.01% 162
2024
Q4 		$81.5K Sell
2,098
-1,042
-33% -$43.8K ﹤0.01% 120
2024
Q3 		$141K Sell
3,140
-55
-2% -$2.46K 0.01% 90
2024
Q2 		$133K Sell
3,195
-75
-2% -$3.13K 0.01% 91
2024
Q1 		$149K Buy
+3,270
New +$149K 0.01% 99
2023
Q4 		– Sell
-3,365
Closed -$137K – 100
2023
Q3 		$137K Buy
3,365
+225
+7% +$10.2K 0.01% 96
2023
Q2 		$152K Buy
3,140
+1
+0% +$50 0.01% 92
2023
Q1 		$155K Buy
3,139
+93
+3% +$4.79K 0.01% 164
2022
Q4 		$154K Sell
3,046
-431
-12% -$22.2K 0.01% 161
2022
Q3 		$175K Buy
+3,477
New +$196K 0.01% 150

Other funds holding GNOM

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return
SH
SLT Holdings Scottsdale, Arizona $160M AUM 52.3% 1-Year Est. Return
WMP
Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return
SWA
Sightline Wealth Advisors Groton, Connecticut $273M AUM 18.08% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $87.6B AUM 131.08% 1-Year Est. Return
AA
Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return
GIA
Gladstone Institutional Advisory Palm Beach Gardens, Florida $3.16B AUM 29.04% 1-Year Est. Return
JWCA
J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Halbert Hargrove Global Advisors's GNOM Position: Q2 2026 in Review

Halbert Hargrove Global Advisors held its Global X Genomics & Biotechnology ETF (GNOM) position steady in Q2 2026 at 1,093 shares worth $62.1K. The position accounts for ﹤0.01% of the portfolio, ranked #200.

Halbert Hargrove Global Advisors first reported a position in GNOM in Q3 2022 and has held it in 15 quarters since. The position peaked at $175K in Q3 2022. 17 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

  • Halbert Hargrove Global Advisors held 1,093 shares of Global X Genomics & Biotechnology ETF worth $62.1K as of Q2 2026.
  • Halbert Hargrove Global Advisors left its Global X Genomics & Biotechnology ETF share count unchanged in Q2 2026.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of Halbert Hargrove Global Advisors's portfolio in Q2 2026, its #200 holding.
  • Halbert Hargrove Global Advisors first reported a position in Global X Genomics & Biotechnology ETF in Q3 2022 and has held it in 15 quarters since.
  • Halbert Hargrove Global Advisors's Global X Genomics & Biotechnology ETF position peaked at $175K in Q3 2022.
  • 17 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.